Madeline Meaney

Madeline Meaney is an Associate Consultant at The Dedham Group, serving as a Senior Analyst on the Cell & Gene Therapy Team. Prior to this role, Madeline worked as an Analyst specializing in oncology and rare diseases. Outside of consulting, Madeline is an Adjunct Professor at Johns Hopkins University Advanced Academic Programs, with a strong focus on biotechnology. Madeline also has experience as a Biotechnology Analyst at an investment start-up company and as a Guest Lecturer at The Johns Hopkins University. Madeline holds a Master of Science in Biotechnology Enterprise and Entrepreneurship from Johns Hopkins University and a Bachelor of Science in Biochemistry Cellular Molecular Biology from the University of Scranton.